Cortechs.ai | Cortechs.ai awarded million dollar NIH grant

Cortechs.ai awarded million dollar NIH grant

The National Institute of Health awards Cortechs.ai a multi-million grant to quantify microstructural changes in Alzheimer’s Disease using Restriction Spectrum Imaging

SAN DIEGO (Aug. 10, 2022) – Cortechs.ai has received a $1.35 million, 2.5-year grant from the National Institutes of Health (NIH), National Institute on Aging to advance Alzheimer’s Disease (AD) diagnosis. The grant will allow Cortechs.ai to deliver an automated AI solution in a clinical setting to enable physicians to quickly determine a patient’s risk of developing AD, monitor disease progression and response to treatment. 

“We are thrilled to receive support from the NIA to further advance this promising technology in the area of Alzheimer’s Disease diagnosis,” said Nathan White, CTO of Cortechs.ai and co-inventor of Restriction Spectrum Imaging. “The development of new therapeutics for prevention and treatment of the disease would greatly benefit from robust, objective quantitative imaging biomarkers that reflect subtle underlying pathological brain changes that occur early in the disease process.”

Alzheimer’s Disease, a progressive neurodegenerative disorder, is characterized by β-amyloid deposits and neurofibrillary tangles preceding neuronal loss and cognitive decline. While diffusion imaging has been used effectively in diseases involving specific white matter pathways, the recent advances in diffusion imaging techniques – particularly multi-compartmental models for successfully quantifying microstructural changes – now enable the effective use of diffusion imaging in Alzheimer’s Disease. The project aims to use an advanced diffusion MRI technique called Restriction Spectrum Imaging to quantify the subtle microstructural changes in Alzheimer’s patients’ brains, making it possible to detect pathological changes in the brain without an autopsy.

Cortechs Labs holds the patent on “Restriction Spectrum Imaging.” The project titled “Quantifying microstructural changes in Alzheimer’s Disease using Restriction Spectrum Imaging” is one of many projects for which Cortechs.ai received research grants.

About Cortechs.ai

Cortechs.ai develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making quantitative analysis of the human brain a routine part of clinical practice. Cortechs.ai’s cutting-edge brain imaging analysis provides neurologists, radiologists, and clinical researchers worldwide with a convenient and cost-effective means to quantify subcortical structures to help assess a variety of neurological conditions, such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma, and brain development abnormalities. Please visit cortechs.ai for further information.

About NIH, National Institute on Aging

NIA, one of the 27 Institutes and Centers of NIH, leads the federal government in conducting and supporting research on aging and the health and well-being of older people. The Institute seeks to understand the nature of aging, the aging process, and diseases and conditions associated with growing older to extend the healthy, active years of life. Please visit nia.nih.gov for further information.

Media Contacts

Cortechs.ai

Dani Kuta

Marketing Manager

dkuta@cortechs.ai

+1 858 459-9700

 

NIH, National Institute on Aging

NIAPressTeam@mail.nih.gov

+1 301 496-1752

More Resources

06/27/2025

Understanding Microvascular Ischemic Disease and the Value of NeuroQuant Microvascular Reports

Accurate, objective data is important in the effort to standardize reporting on vascular lesions and their associated pathologies.

06/16/2025

Seeing Alzheimer’s More Clearly: How PET Imaging Is Changing the Game

PET imaging is transforming how we detect and monitor Alzheimer’s disease, enabling earlier diagnosis, better disease tracking, and more personalized treatment.

06/11/2025

Cortechs.ai and RMS Medical Devices Forge Distribution Partnership to Expand Access to AI-Powered Imaging Solutions in the Benelux Region

We’re excited to announce our new partnership with RMS Medical Devices to our advanced neuroimaging and prostate imaging solutions to the Benelux region

06/04/2025

Cortechs.ai and deepc Announce Strategic Partnership to Advance AI Integration in Radiology

Press Release: Delivering Clinically Validated AI Solutions for Enhanced Imaging Precision and Workflow Efficiency

05/29/2025

Enhancing Imaging Workflow with DICOM SR: NeuroQuant®’s Seamless Integration 

As imaging becomes more data-driven, tools like NeuroQuant® with DICOM SR support pave the way for smarter, more connected radiology

05/18/2025

Cortechs.ai and ALZ-NET Announce Strategic Collaboration to Improve Alzheimer’s Disease Care Through AI-Driven Imaging

This new strategic collaboration aims to enhance the quality of care for people living with Alzheimer’s disease.
Scroll to Top